[1]李 玲),张芳文),王冠男),等.原发睾丸淋巴瘤的临床特点及预后影响因素分析*[J].郑州大学学报(医学版),2017,(04):470-474.[doi:10.13705/j.issn.1671-6825.2017.04.024]
 LI Ling),ZHANG Fangwen),WANG Guannan),et al.Clinical characteristics and prognosis influnencing factors of primary testicular lymphoma[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2017,(04):470-474.[doi:10.13705/j.issn.1671-6825.2017.04.024]
点击复制

原发睾丸淋巴瘤的临床特点及预后影响因素分析*()
分享到:

《郑州大学学报(医学版)》[ISSN:1671-6825/CN:41-1340/R]

卷:
期数:
2017年04期
页码:
470-474
栏目:
应用研究
出版日期:
2017-07-15

文章信息/Info

Title:
Clinical characteristics and prognosis influnencing factors of primary testicular lymphoma
作者:
李 玲1)张芳文1)王冠男2)张 蕾1)李 鑫1)段文静1)李文才2)张明智 1)#
1)郑州大学第一附属医院肿瘤科 郑州 450052 2)郑州大学第一附属医院病理科 郑州 450052
Author(s):
LI Ling1)ZHANG Fangwen1)WANG Guannan2)ZHANG Lei1)LI Xin1)DUAN Wenjing1)LI Wencai2)ZHANG Mingzhi1)
1)Department of Oncology, the First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052;
2)Department of Pathology, the First Affiliated Hospital,Zhengzhou University, Zhengzhou 450052
关键词:
原发睾丸淋巴瘤 临床特点 预后
Keywords:
primary testicular lymphoma clinical characteristic prognosis
分类号:
R737.21
DOI:
10.13705/j.issn.1671-6825.2017.04.024
摘要:
目的:探讨原发睾丸淋巴瘤(PTL)患者的临床特点和预后影响因素。方法:回顾性分析28例PTL患者的临床资料,以Kaplan-Meier法绘制生存曲线,Log-rank检验进行PTL患者预后的单因素分析,采用COX回归模型评估预后独立的影响因素。结果:经4~7周期化疗和(或)放疗后,其中死亡8例,完全缓解9例(32.1%),部分缓解8例(28.6%),疾病进展3例(10.7%)。客观缓解率为60.7%(17/28)。无疾病进展期12.4个月,总生存期35.1个月,中位随访时间35(6~90)个月。COX回归分析结果显示结外受侵个数、病理类型和B症状是PTL预后的独立影响因素[β=2.122,2.269,1.971; HR=8.346,9.668,7.175; 95%CI=1.159~60.088,1.526~61.230,1.170~44.007]。结论:结外受侵个数、病理类型和B症状是影响PTL患者预后的重要因素。
Abstract:
Aim: To investigate the clinical characteristics and factors affecting prognosis of patients with primary testicular lymphoma(PTL).Methods: A retrospective analysis of 28 cases with PTL admitted in the First Affiliated Hospital of Zhengzhou University from September, 2001 to July, 2014 were carried out. Survival curve was estimated using Kaplan-Meier method. Univariate analysis of prognosis in patients with PTL was performed by the Log-rank test. Multivariate analysis using COX regression models was performed to assess independent prognostic factors.Results: After treatment of 4-7 cycles chemotherapy and(or)radiotherapy, 8 patients were dead, 9 patients achieved complete remission(32.1%), 8 patients achieved partial remission(28.6%), 3 patients resulted in progression of disease(10.7%). The objective remission rate was 60.7%(17/28). The progression-free survival was 12.4 months. The overall survival was 35.1 months. The median follow-up time was 35(6-90)months. COX regression analysis indicated that the number of extranodal invasion, the type of pathology and B symptoms were independent prognostic factors of PTL(β=2.122,2.269,1.971; HR=8.346,9.668,7.175; 95%CI=1.159-60.088,1.526-61.230,1.170-44.007).Conclusion: The number of extranodal invasion, pathological types and B symptoms are important prognostic factors for prognosis of PTL.

参考文献/References:

[1] KEMAL Y, TEKER F, DEMIRAG G,et al.Frimary testicular lymphoma: a single center experience[J].Exp Oncol,2015,37(3):223
[2] KIM J,YOON DH,PARK I,et al.Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience[J].Blood Res,2014,49(3):170
[3] LOKESH KN,SATHYANARAYANAN V,KUNTEGOWDANAHALLI CL,et al.Primary Diffuse large B-Cell lymphoma of testis: A single centre experience and review of literature[J].Urol Ann,2014,6(3):231
[4] BADYAL RK,KATARIA AS.Primary bilateral plasmablastic lymphoma of the testis in a human immunodeficiency virus positive man[J].Indian J Sex Transm Dis,2015,36(1):86
[5] TOMBOLINI F,LACETERA V,GINI G,et al.Primary B-cell lymphoblastic lymphoma of the testis[J].Arch Ital Urol Androl,2014,30,86(4):400
[6] HUDOLIN T,KASTELAN Z,ILIC I,et al.Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma[J].J Transl Med,2013,11:123
[7] MLIKA M,CHELLY I,BENRHOUMA M,et al.A primary testicular diffuse large B-cell lymphoma belonging to the germinal center B-cell-like group[J].J Clin Med Res,2010,2(1):47
[8] MIHALJEVIC B,VUKOVIC V,SMILJANIC M,et al.Single-center experiment in the treatment of primary testicular lymphoma[J].Oncol Res Treat,2014,37(5):239
[9] CHEAH CY,WIRTH A,SEYMOUR JF.Primary testicular lymphoma[J].Blood,2014,123(4):486
[10]WANG C,WANG H,WANG Q,et al.Primary testicular lymphoma: experience with 13 cases and literature review[J].Int J Hematol,2013,97(2):240
[11]VITOLO U,CHIAPPELLA A,FERRERI AJ,et al.First-line treatment for primary testicular diffuse large B-cell lymphoma with rituximab-CHOP, CNS prophylaxis, and contralateral testis irradiation: final results of an international phase II trial[J].J Clin Oncol,2011,29(20):2766
[12]TONDINI C,FERRERI AJ,SIRACUSANO L,et al.Diffuse large-cell lymphoma of the testis[J].J Clin Oncol,1999,17(2):2854

相似文献/References:

[1]樊冰雨),鲍启德),孙 雷),等.食管癌高、低发区食管鳞癌相关多原发癌的临床特点[J].郑州大学学报(医学版),2019,(02):160.[doi:10.13705/j.issn.1671-6825.2018.12.077]
 FAN Bingyu),BAO Qide),SUN Lei),et al.Clinical characteristics of multiple primary malignancies associated with esophageal squamous carcinoma from high- and low- incidence areas[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(04):160.[doi:10.13705/j.issn.1671-6825.2018.12.077]
[2]李婷婷),张迎娜),吕 杰),等.河南省抗GQ1b抗体综合征患者临床特点分析[J].郑州大学学报(医学版),2019,(02):231.[doi:10.13705/j.issn.1671-6825.2018.09.123]
 LI Tingting),ZHANG Yingna),LYU Jie),et al.Clinical characteristics of patients with anti-GQ1b antibody syndrome in Henan Province[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(04):231.[doi:10.13705/j.issn.1671-6825.2018.09.123]
[3]李延娟,张 澍,桑丽娜,等.症状性华氏巨球蛋白血症患者的临床特征及预后影响因素分析[J].郑州大学学报(医学版),2019,(04):627.[doi:10.13705/j.issn.1671-6825.2018.11.056]
 LI Yanjuan,ZHANG Shu,SANG Lina,et al.Clinical features and prognostic factors of patients with symptomatic Waldenstrm's macroglobulinemia[J].JOURNAL OF ZHENGZHOU UNIVERSITY(MEDICAL SCIENCES),2019,(04):627.[doi:10.13705/j.issn.1671-6825.2018.11.056]

备注/Memo

备注/Memo:
*国家自然科学基金项目 81570204; 河南省高校科技创新人才支持计划项目 16HASTIT028
#通信作者,男,1962年10月生,教授,主任医师,研究方向:淋巴瘤的基础与临床,E-mail:mingzhi_zhang@126.com
更新日期/Last Update: 2017-07-20